Skip to main content
Stephen Clark, MD, Neurology, Murfreesboro, TN

StephenWesleyClarkMDPhD, MSCI

Neurology Murfreesboro, TN

Chief Medical Officer, Epiphany Biosciences

Dr. Clark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Clark's full profile

Already have an account?

  • Office

    520 Highland Ter Ste D
    Murfreesboro, TN 37130
    Phone+1 615-802-5900

Education & Training

  • Vanderbilt University
    Vanderbilt University MSCI, Master's of Science in Clinical Investigation, 2014 - 2016
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Neuro-Oncology, 2010 - 2011
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Neurology, 2007 - 2010
  • East Tennessee State University/Quillen College of Medicine
    East Tennessee State University/Quillen College of MedicineResidency, Internship, 2006 - 2007
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterInternship, Pathology-Anatomic and Clinical, 2005 - 2006
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 2005

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2011 - 2026
  • TX State Medical License
    TX State Medical License 2010 - 2026
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Cannabis Usage Furthers the Risk of Delayed Cerebral Ischemia
    Cannabis Usage Furthers the Risk of Delayed Cerebral IschemiaJanuary 7th, 2022
  • Combined Modality Therapy Superior in Glioblastoma
    Combined Modality Therapy Superior in GlioblastomaMay 24th, 2016
  • Potential treatment for a subtype of glioblastoma tumors.
    Potential treatment for a subtype of glioblastoma tumors. June 11th, 2022
  • Join now to see all